|
US2642514A
(en)
|
1946-08-10 |
1953-06-16 |
American Cyanamid Co |
Ion exchange process with magnetic ion exchange resins
|
|
GB1239978A
(en)
|
1968-07-15 |
1971-07-21 |
Permutt Company Ltd |
Ion-exchange processes
|
|
US5650270A
(en)
|
1982-02-01 |
1997-07-22 |
Northeastern University |
Molecular analytical release tags and their use in chemical analysis
|
|
US4650750A
(en)
|
1982-02-01 |
1987-03-17 |
Giese Roger W |
Method of chemical analysis employing molecular release tag compounds
|
|
US4709016A
(en)
|
1982-02-01 |
1987-11-24 |
Northeastern University |
Molecular analytical release tags and their use in chemical analysis
|
|
US5516931A
(en)
|
1982-02-01 |
1996-05-14 |
Northeastern University |
Release tag compounds producing ketone signal groups
|
|
US5595756A
(en)
|
1993-12-22 |
1997-01-21 |
Inex Pharmaceuticals Corporation |
Liposomal compositions for enhanced retention of bioactive agents
|
|
US20020164788A1
(en)
|
1994-12-02 |
2002-11-07 |
The Wellcome Foundation Limited |
Humanized antibodies to CD38
|
|
CA2229043C
(en)
|
1995-08-18 |
2016-06-07 |
Morphosys Gesellschaft Fur Proteinoptimierung Mbh |
Protein/(poly)peptide libraries
|
|
WO1998019705A1
(en)
|
1996-11-05 |
1998-05-14 |
Bristol-Myers Squibb Company |
Branched peptide linkers
|
|
US6410275B1
(en)
|
1997-05-02 |
2002-06-25 |
Biomerieux, Inc. |
Disposable test devices for performing nucleic acid amplification reactions
|
|
US6326144B1
(en)
|
1998-09-18 |
2001-12-04 |
Massachusetts Institute Of Technology |
Biological applications of quantum dots
|
|
DE69938353T2
(de)
|
1998-09-24 |
2009-03-05 |
Indiana University Research and Technology Corp., Indianapolis |
Wasserlösliche lumineszente quantum-dots sowie deren biokonjugate
|
|
US6927203B1
(en)
|
1999-08-17 |
2005-08-09 |
Purdue Research Foundation |
Treatment of metastatic disease
|
|
CZ303875B6
(cs)
|
1999-12-10 |
2013-06-05 |
Pfizer Products Inc. |
Pyrrolo[2,3-d]pyrimidinová sloucenina a farmaceutická kompozice s jejím obsahem
|
|
PE20020354A1
(es)
|
2000-09-01 |
2002-06-12 |
Novartis Ag |
Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
|
|
US7071189B2
(en)
|
2001-04-27 |
2006-07-04 |
Zenyaku Kogyo Kabushiki Kaisha |
Heterocyclic compound and antitumor agent containing the same as active ingredient
|
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
CA2477163C
(en)
|
2002-02-21 |
2010-07-27 |
Institute Of Virology |
Soluble form of carbonic anhydrase ix (s-ca-ix), assays to detect s-ca ix, and ca ix's coexpression with her-2/neu/c-erbb-2, and ca ix-specific monoclonal antibodies to non-immunodominant epitopes
|
|
CN1674929B
(zh)
|
2002-08-14 |
2013-07-17 |
赛伦斯治疗公司 |
蛋白激酶Nβ的应用
|
|
EP1569956B1
(en)
|
2002-12-12 |
2014-02-26 |
Tel Aviv University Future Technology Development L.P. |
Glycogen synthase kinase-3 inhibitors
|
|
EP1452868A2
(en)
|
2003-02-27 |
2004-09-01 |
Pepscan Systems B.V. |
Method for selecting a candidate drug compound
|
|
KR20070087266A
(ko)
|
2003-04-03 |
2007-08-28 |
세마포르 파머슈티컬즈, 아이엔씨. |
피아이-3 키나아제 억제제 프로드러그
|
|
AU2004242928B2
(en)
|
2003-05-30 |
2011-03-10 |
Gemin X Pharmaceuticals Canada Inc. |
Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
|
|
EP2371835A1
(en)
|
2003-07-03 |
2011-10-05 |
The Trustees Of The University Of Pennsylvania |
Inhibition of syk kinase expression
|
|
JP2008504013A
(ja)
|
2004-02-06 |
2008-02-14 |
モルフォシス・アクチェンゲゼルシャフト |
抗ｃｄ３８ヒト抗体及びその用途
|
|
US7151047B2
(en)
|
2004-04-28 |
2006-12-19 |
Warren Chan |
Stable, water-soluble quantum dot, method of preparation and conjugates thereof
|
|
WO2005113556A1
(en)
|
2004-05-13 |
2005-12-01 |
Icos Corporation |
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
|
|
TWI380996B
(zh)
|
2004-09-17 |
2013-01-01 |
Hoffmann La Roche |
抗ｏｘ４０ｌ抗體
|
|
US7449458B2
(en)
|
2005-01-19 |
2008-11-11 |
Rigel Pharmaceuticals, Inc. |
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
|
|
SI1844337T1
(sl)
*
|
2005-01-24 |
2013-11-29 |
Pepscan Systems B.V. |
Povezovalne spojine, imunogene spojine in peptidomimetiki
|
|
KR101314899B1
(ko)
|
2005-03-22 |
2013-10-04 |
로도세이야구가부시기가이샤 |
콜라겐 또는 히알루론산 생성을 증가시키는 펩티드
|
|
ES2657443T3
(es)
|
2005-03-25 |
2018-03-05 |
Gitr, Inc. |
Anticuerpos anti-GITR y usos de los mismos
|
|
DK1888550T3
(da)
|
2005-05-12 |
2014-09-29 |
Abbvie Bahamas Ltd |
Apoptosepromotorer
|
|
GB0510390D0
(en)
|
2005-05-20 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
|
KR101411165B1
(ko)
|
2005-07-01 |
2014-06-25 |
메다렉스, 엘.엘.시. |
예정 사멸 리간드 1 (피디-엘1)에 대한 인간 모노클로날항체
|
|
US7402325B2
(en)
|
2005-07-28 |
2008-07-22 |
Phoenix Biotechnology, Inc. |
Supercritical carbon dioxide extract of pharmacologically active components from Nerium oleander
|
|
CA2621502A1
(en)
|
2005-09-07 |
2007-03-15 |
Medimmune, Inc. |
Toxin conjugated eph receptor antibodies
|
|
WO2007044729A2
(en)
|
2005-10-07 |
2007-04-19 |
Exelixis, Inc. |
N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors
|
|
MY167260A
(en)
|
2005-11-01 |
2018-08-14 |
Targegen Inc |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
|
KR101391900B1
(ko)
|
2005-12-13 |
2014-05-02 |
인사이트 코포레이션 |
야누스 키나아제 억제제로서의 헤테로아릴 치환된 피롤로［2,3-ｂ］피리딘 및 피롤로［2,3-ｂ］피리미딘
|
|
JO2660B1
(en)
|
2006-01-20 |
2012-06-17 |
نوفارتيس ايه جي |
Pi-3 inhibitors and methods of use
|
|
WO2007093836A1
(en)
|
2006-02-13 |
2007-08-23 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from a xp gene and uses thereof
|
|
UA95799C2
(en)
|
2006-04-26 |
2011-09-12 |
Ф. Хоффманн-Ля Рош Аг |
Pharmaceutical compounds
|
|
WO2008033561A2
(en)
|
2006-09-15 |
2008-03-20 |
Siemens Medical Solutions Usa, Inc. |
Click chemistry-derived cyclopeptide derivatives as imaging agents for integrins
|
|
EP2526934B1
(en)
|
2006-09-22 |
2015-12-09 |
Pharmacyclics LLC |
Inhibitors of bruton's tyrosine kinase
|
|
CN101232326B
(zh)
|
2007-01-22 |
2012-01-11 |
中兴通讯股份有限公司 |
用于无源光网络系统的动态带宽分配装置及其实现方法
|
|
HUE029188T2
(en)
|
2007-03-12 |
2017-03-28 |
Ym Biosciences Australia Pty |
Phenylamino-pyrimidine compounds and their use
|
|
WO2008118802A1
(en)
|
2007-03-23 |
2008-10-02 |
Regents Of The University Of Minnesota |
Therapeutic compounds
|
|
WO2008134761A2
(en)
|
2007-04-30 |
2008-11-06 |
Intezyne Technologies, Inc. |
Modification of biological targeting groups for the treatment of cancer
|
|
EP1987839A1
(en)
|
2007-04-30 |
2008-11-05 |
I.N.S.E.R.M. Institut National de la Sante et de la Recherche Medicale |
Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease
|
|
PE20090717A1
(es)
|
2007-05-18 |
2009-07-18 |
Smithkline Beecham Corp |
Derivados de quinolina como inhibidores de la pi3 quinasa
|
|
JP2010530437A
(ja)
|
2007-06-18 |
2010-09-09 |
メディミューン，エルエルシー |
ＥｐｈＡ２およびＥｒｂＢ２を発現する細胞の相乗的治療
|
|
US8591886B2
(en)
|
2007-07-12 |
2013-11-26 |
Gitr, Inc. |
Combination therapies employing GITR binding molecules
|
|
EP2044949A1
(en)
|
2007-10-05 |
2009-04-08 |
Immutep |
Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response
|
|
CA2932121A1
(en)
|
2007-11-30 |
2009-06-11 |
Newlink Genetics Corporation |
Ido inhibitors
|
|
US9422234B2
(en)
|
2007-11-30 |
2016-08-23 |
The Johns Hopkins University |
Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of prostate cancer
|
|
WO2009097397A2
(en)
|
2008-01-30 |
2009-08-06 |
Dyax Corp. |
Metalloproteinase binding proteins
|
|
CN101497878B
(zh)
|
2008-01-30 |
2012-11-07 |
房学迅 |
特异性高效亲和膜ⅰ型基质金属蛋白酶(mt1-mmp)的多肽、蛋白及其应用
|
|
US8680022B2
(en)
|
2008-02-05 |
2014-03-25 |
Bicycle Therapeutics Limited |
Methods and compositions
|
|
MX2010009530A
(es)
|
2008-02-27 |
2010-11-30 |
Yeda Res & Dev |
Conjugados de rgd-(bacterio) clorofila para terapia fotodinámica y formación de imágenes de tumores necróticos.
|
|
MX2010010012A
(es)
|
2008-03-11 |
2010-10-20 |
Incyte Corp |
Derivados de azetidina y ciclobutano como inhibidores de jak.
|
|
US8293714B2
(en)
|
2008-05-05 |
2012-10-23 |
Covx Technology Ireland, Ltd. |
Anti-angiogenic compounds
|
|
FR2932189A1
(fr)
|
2008-06-10 |
2009-12-11 |
Commissariat Energie Atomique |
Biopuces pour la detection de l'activite enzymatique d'une enzyme protease
|
|
US8338439B2
(en)
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
|
AR072999A1
(es)
|
2008-08-11 |
2010-10-06 |
Medarex Inc |
Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos
|
|
WO2010077634A1
(en)
|
2008-12-09 |
2010-07-08 |
Genentech, Inc. |
Anti-pd-l1 antibodies and their use to enhance t-cell function
|
|
GB0913775D0
(en)
|
2009-08-06 |
2009-09-16 |
Medical Res Council |
Multispecific peptides
|
|
AU2010249719A1
(en)
|
2009-05-19 |
2012-05-31 |
Aic Blab Company |
Composite current collector and methods therefor
|
|
GB0914110D0
(en)
|
2009-08-12 |
2009-09-16 |
Medical Res Council |
Peptide libraries
|
|
CA2772613C
(en)
|
2009-09-03 |
2020-03-10 |
Schering Corporation |
Anti-gitr antibodies
|
|
US8722720B2
(en)
|
2009-10-28 |
2014-05-13 |
Newlink Genetics Corporation |
Imidazole derivatives as IDO inhibitors
|
|
AU2010321738B2
(en)
|
2009-11-23 |
2016-07-14 |
Palatin Technologies, Inc. |
Melanocortin-1 receptor-specific cyclic peptides
|
|
PL2949670T3
(pl)
|
2009-12-10 |
2019-07-31 |
F. Hoffmann-La Roche Ag |
Przeciwciała wiążące się preferencyjnie z zewnątrzkomórkową domeną 4 ludzkiego CSF-1R i ich zastosowanie
|
|
US9073974B2
(en)
|
2009-12-21 |
2015-07-07 |
The Regents Of The University Of California |
RGD-containing cyclic peptides
|
|
EP2343081A1
(en)
|
2009-12-31 |
2011-07-13 |
Rijksuniversiteit Groningen |
Interferon analogs
|
|
US9150656B2
(en)
|
2010-03-04 |
2015-10-06 |
Macrogenics, Inc. |
Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof
|
|
US9169323B2
(en)
|
2010-03-05 |
2015-10-27 |
Hoffmann-La Roche Inc. |
Antibodies against human CSF-1R
|
|
US9221910B2
(en)
|
2010-03-05 |
2015-12-29 |
Hoffmann-La Roche Inc. |
Antibodies against human CSF-1R
|
|
AU2011248083B2
(en)
|
2010-05-04 |
2015-09-10 |
Five Prime Therapeutics, Inc. |
Antibodies that bind CSF1R
|
|
MX337040B
(es)
|
2010-09-09 |
2016-02-09 |
Pfizer |
Moleculas de union a 4-1bb.
|
|
WO2012057624A1
(en)
|
2010-10-25 |
2012-05-03 |
Pepscan Systems B.V. |
Novel bicyclic peptide mimetics
|
|
PH12013501201A1
(en)
|
2010-12-09 |
2013-07-29 |
Univ Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
|
US20130072598A1
(en)
|
2011-03-18 |
2013-03-21 |
Board Of Regents Of The University Of Nebraska |
Thermoplastics from Distillers Dried Grains and Feathers
|
|
NO2694640T3
(enExample)
|
2011-04-15 |
2018-03-17 |
|
|
|
PL2699264T3
(pl)
|
2011-04-20 |
2018-08-31 |
Medimmune, Llc |
Przeciwciała i inne cząsteczki wiążące B7-H1 i PD-1
|
|
PL2764140T3
(pl)
|
2011-10-07 |
2018-04-30 |
Bicyclerd Limited |
Modulacja specyficzności polipeptydów ustrukturyzowanych
|
|
GB201117428D0
(en)
|
2011-10-07 |
2011-11-23 |
Bicycle Therapeutics Ltd |
Structured polypeptides with sarcosine linkers
|
|
EP2785375B1
(en)
|
2011-11-28 |
2020-07-22 |
Merck Patent GmbH |
Anti-pd-l1 antibodies and uses thereof
|
|
CA2853889A1
(en)
|
2011-12-15 |
2013-06-20 |
F. Hoffmann-La Roche Ag |
Antibodies against human csf-1r and uses thereof
|
|
BR112014018961A8
(pt)
|
2012-02-06 |
2017-07-11 |
Genentech Inc |
Anticorpo isolado, anticorpo biespecífico, fragmento, ácido nucleico isolado, vetor, célula hospedeira, método de produção de anticorpos, composição farmacêutica, uso do anticorpo, método de tratamento, método de inibição e artigo industrializado
|
|
AR090263A1
(es)
|
2012-03-08 |
2014-10-29 |
Hoffmann La Roche |
Terapia combinada de anticuerpos contra el csf-1r humano y las utilizaciones de la misma
|
|
HK1208233A1
(en)
|
2012-05-11 |
2016-02-26 |
戊瑞治疗有限公司 |
Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (csf1r)
|
|
AR091649A1
(es)
|
2012-07-02 |
2015-02-18 |
Bristol Myers Squibb Co |
Optimizacion de anticuerpos que se fijan al gen de activacion de linfocitos 3 (lag-3) y sus usos
|
|
EP2890398A4
(en)
|
2012-08-31 |
2016-03-09 |
Five Prime Therapeutics Inc |
METHODS OF TREATING DISEASES WITH ANTIBODIES THAT BIND COLONY STIMULATING FACTOR RECEIVER 1 (CSF1R)
|
|
BR112015006368B1
(pt)
|
2012-09-24 |
2022-02-08 |
Medimmune Limited |
Processo para produção de linha celular eucariótica estável
|
|
WO2014063012A1
(en)
|
2012-10-19 |
2014-04-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Conjugated knottin mini-proteins containing non-natural amino acids
|
|
EP3666795A1
(en)
|
2013-03-12 |
2020-06-17 |
Molecular Templates, Inc. |
Cytotoxic proteins comprising cell-targeting binding regions and shiga toxin a subunit regions for selective killing of specific cell types
|
|
US20140274759A1
(en)
|
2013-03-15 |
2014-09-18 |
Bicycle Therapeutics Limited |
Modification of polypeptides
|
|
WO2014142237A1
(ja)
|
2013-03-15 |
2014-09-18 |
日本ゼオン株式会社 |
中空重合体粒子の水性分散液およびその製造方法
|
|
JP6574754B2
(ja)
|
2013-03-19 |
2019-09-11 |
ベイジン シェノゲン ファーマ グループ リミテッド |
エストロゲン受容体関連疾患を処置するための抗体及び方法
|
|
GB201306623D0
(en)
|
2013-04-11 |
2013-05-29 |
Bicycle Therapeutics Ltd |
Modulation of structured polypeptide specificity
|
|
WO2014190257A2
(en)
|
2013-05-23 |
2014-11-27 |
Ohio State Innovation Foundation |
Chemical synthesis and screening of bicyclic peptide libraries
|
|
IL291329B1
(en)
|
2013-09-25 |
2025-09-01 |
Cytomx Therapeutics Inc |
Polypeptides that can be determined in matrix metalloproteinases and uses thereof
|
|
SG11201602889TA
(en)
|
2013-10-28 |
2016-05-30 |
Bicycle Therapeutics Ltd |
Novel polypeptides
|
|
KR102408261B1
(ko)
|
2014-02-03 |
2022-06-10 |
비타이 파마슈티컬즈, 엘엘씨 |
Ror-감마의 디하이드로피롤로피리딘 저해제
|
|
JP6875129B2
(ja)
|
2014-05-08 |
2021-05-19 |
ノボダイアックス， インコーポレイテッド |
直接的な免疫組織化学アッセイ
|
|
PL3149025T3
(pl)
|
2014-05-21 |
2019-11-29 |
Entrada Therapeutics Inc |
Peptydy penetrujące komórkę i sposoby ich wytwarzania i stosowania
|
|
GB201416960D0
(en)
|
2014-09-25 |
2014-11-12 |
Antikor Biopharma Ltd |
Biological materials and uses thereof
|
|
US10654897B2
(en)
|
2014-09-30 |
2020-05-19 |
Polyphor Ag |
β-hairpin peptidomimetics
|
|
WO2016065258A1
(en)
|
2014-10-24 |
2016-04-28 |
Research Corporation Technologies, Inc. |
Small antibody-like polypeptides that bind to epha2 receptor
|
|
US10532106B2
(en)
|
2014-10-29 |
2020-01-14 |
Bicyclerd Limited |
Bicyclic peptide ligands specific for MT1-MMP
|
|
WO2016070089A2
(en)
|
2014-10-31 |
2016-05-06 |
Abbvie Biotherapeutics Inc. |
Anti-cs1 antibodies and antibody drug conjugates
|
|
CN114656483A
(zh)
|
2014-12-04 |
2022-06-24 |
细胞基因公司 |
生物分子共轭物
|
|
IL237525A
(en)
|
2015-03-03 |
2017-05-29 |
Shalom Eli |
Method for labeling a prostate-specific membrane antigen with a radioactive isotope
|
|
EP3287027B1
(en)
|
2015-04-22 |
2021-07-28 |
Mitsui Chemicals, Inc. |
Clothing provided with joint supporter portion, and knee supporter
|
|
WO2016171242A1
(ja)
|
2015-04-24 |
2016-10-27 |
第一三共株式会社 |
Ｅｐｈａ２の検出
|
|
AU2016256226A1
(en)
|
2015-04-28 |
2017-11-23 |
Ecole polytechnique fédérale de Lausanne (EPFL) |
Novel inhibitors of the enzyme activated factor XII (FXIIa)
|
|
HK1253005A1
(zh)
*
|
2015-05-06 |
2019-06-06 |
Janssen Biotech, Inc. |
前列腺特异性膜抗原结合iii型纤连蛋白结构域
|
|
EP3115066A1
(en)
|
2015-07-07 |
2017-01-11 |
Technische Universität München |
Novel psma-specific binding proteins
|
|
US9963495B2
(en)
*
|
2015-10-27 |
2018-05-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Polypeptides targeting vascular endothelial growth factor receptor and prostate specific membrane antigen
|
|
EP3181146A1
(en)
|
2015-12-16 |
2017-06-21 |
Ruprecht-Karls-Universität Heidelberg |
Cyclic ntcp-targeting peptides and their uses as entry inhibitors
|
|
GB201600911D0
(en)
|
2016-01-18 |
2016-03-02 |
Bicycle Therapeutics Ltd |
Stabilized peptide derivatives
|
|
WO2017160879A1
(en)
*
|
2016-03-15 |
2017-09-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Knottin-drug conjugates and methods of using the same
|
|
CN108883199A
(zh)
|
2016-03-16 |
2018-11-23 |
梅里麦克制药股份有限公司 |
肝配蛋白受体a2(epha2)的纳米脂质体靶向和相关诊断
|
|
MA45328A
(fr)
|
2016-04-01 |
2019-02-06 |
Avidity Biosciences Llc |
Compositions acide nucléique-polypeptide et utilisations de celles-ci
|
|
KR102295190B1
(ko)
|
2016-04-20 |
2021-08-30 |
항저우 디에이씨 바이오테크 씨오, 엘티디 |
아마니타 독소의 유도체 및 세포 결합 분자와의 그것의 결합
|
|
KR102426765B1
(ko)
|
2016-04-22 |
2022-07-29 |
엘리게이터 바이오사이언스 에이비 |
Cd137에 대한 신규한 이중특이성 폴리펩타이드
|
|
GB201607827D0
(en)
|
2016-05-04 |
2016-06-15 |
Bicycle Therapeutics Ltd |
Bicyclic peptide-toxin conjugates specific for MT1-MMP
|
|
CA3025345A1
(en)
|
2016-05-27 |
2017-11-30 |
Abbvie Biotherapeutics Inc. |
Bispecific binding proteins binding an immunomodulatory protein and a tumor antigen
|
|
WO2018096365A1
(en)
|
2016-11-27 |
2018-05-31 |
Bicyclerd Limited |
Methods for treating cancer
|
|
JP7387440B2
(ja)
|
2016-12-23 |
2023-11-28 |
バイスクルテクス・リミテッド |
Ｍｔ１－ｍｍｐに結合するためのペプチドリガンド
|
|
JP2020502238A
(ja)
|
2016-12-23 |
2020-01-23 |
バイスクルアールディー・リミテッド |
新規連結構造を有するペプチド誘導体
|
|
US10624968B2
(en)
|
2017-01-06 |
2020-04-21 |
Bicyclerd Limited |
Compounds for treating cancer
|
|
EP3585431A4
(en)
|
2017-02-24 |
2020-12-16 |
MacroGenics, Inc. |
BISPECIFIC BINDING MOLECULES CAPABLE OF BINDING TO CD137 AND TUMOR ANTIGENS, AND THEIR USES
|
|
GB201706477D0
(en)
|
2017-04-24 |
2017-06-07 |
Bicycle Therapeutics Ltd |
Modification of polypeptides
|
|
US10857196B2
(en)
|
2017-04-27 |
2020-12-08 |
Bicycletx Limited |
Bicyclic peptide ligands and uses thereof
|
|
WO2018222987A1
(en)
|
2017-06-01 |
2018-12-06 |
Tarveda Therapeutics, Inc. |
Targeted constructs
|
|
WO2019002842A1
(en)
|
2017-06-26 |
2019-01-03 |
Bicyclerd Limited |
BICYCLIC PEPTIDE LIGANDS WITH DETECTABLE FRACTIONS AND USES THEREOF
|
|
CN111183147B
(zh)
|
2017-08-04 |
2024-07-05 |
拜斯科技术开发有限公司 |
Cd137特异性的双环肽配体
|
|
US20200291096A1
(en)
|
2017-08-14 |
2020-09-17 |
Bicyclerd Limited |
Bicyclic peptide ligand sting conjugates and uses thereof
|
|
WO2019034868A1
(en)
|
2017-08-14 |
2019-02-21 |
Bicyclerd Limited |
CONJUGATES PEPTIDE BICYCLIC-LIGAND PPR-A AND USES THEREOF
|
|
WO2019084060A1
(en)
|
2017-10-24 |
2019-05-02 |
Silverback Therapeutics, Inc. |
CONJUGATES AND METHODS OF USE FOR THE SELECTIVE DELIVERY OF IMMUNOMODULATORY AGENTS
|
|
CA3080857A1
(en)
|
2017-11-07 |
2019-05-16 |
Regeneron Pharmaceuticals, Inc. |
Hydrophilic linkers for antibody drug conjugates
|
|
GB201721265D0
(en)
|
2017-12-19 |
2018-01-31 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for EphA2
|
|
TWI825046B
(zh)
|
2017-12-19 |
2023-12-11 |
英商拜西可泰克斯有限公司 |
Epha2特用之雙環胜肽配位基
|
|
WO2019136442A1
(en)
|
2018-01-08 |
2019-07-11 |
Kleo Pharmaceuticals, Inc. |
Cd16a binding agents and uses thereof
|
|
JP2021514953A
(ja)
|
2018-02-23 |
2021-06-17 |
バイスクルテクス・リミテッド |
多量体二環式ペプチドリガンド
|
|
KR20200139236A
(ko)
|
2018-04-04 |
2020-12-11 |
바이사이클티엑스 리미티드 |
헤테로탠덤 비사이클릭 펩티드 복합체
|
|
AU2019272575A1
(en)
|
2018-05-21 |
2020-12-10 |
Compass Therapeutics Llc |
Compositions and methods for enhancing the killing of target cells by NK cells
|
|
US11180531B2
(en)
|
2018-06-22 |
2021-11-23 |
Bicycletx Limited |
Bicyclic peptide ligands specific for Nectin-4
|
|
GB201810327D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicycletx Ltd |
Peptide ligands for binding to IL-17
|
|
GB201810325D0
(en)
*
|
2018-06-22 |
2018-08-08 |
Bicycletx Ltd |
Peptide ligands for binding to PSMA
|
|
GB201810320D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicycletx Ltd |
Peptide ligands for binding to CD38
|
|
GB201810316D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicyclerd Ltd |
Peptide ligands for binding to EphA2
|
|
GB201810329D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicycletx Ltd |
Peptide ligands for binding to integrin avB3
|
|
US10919937B2
(en)
|
2018-10-23 |
2021-02-16 |
Bicycletx Limited |
Bicyclic peptide ligands and uses thereof
|
|
CA3116504A1
(en)
|
2018-10-30 |
2020-05-07 |
Bicyclerd Limited |
Bt1718 for use in treating cancer
|
|
BR112021011340A2
(pt)
|
2018-12-13 |
2021-09-08 |
Bicycletx Limited |
Ligantes de peptídeo bicíclico específicos para mt1-mmp
|
|
GB201820288D0
(en)
|
2018-12-13 |
2019-01-30 |
Bicycle Tx Ltd |
Bicycle peptide ligaands specific for MT1-MMP
|
|
GB201820325D0
(en)
|
2018-12-13 |
2019-01-30 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for psma
|
|
GB201820295D0
(en)
|
2018-12-13 |
2019-01-30 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for MT1-MMP
|
|
AU2019402097A1
(en)
|
2018-12-17 |
2021-06-10 |
Revitope Limited |
Twin immune cell engager
|
|
CN113260420A
(zh)
|
2018-12-21 |
2021-08-13 |
拜斯科阿迪有限公司 |
Pd-l1特异性的双环肽配体
|
|
WO2020128526A1
(en)
|
2018-12-21 |
2020-06-25 |
Bicycletx Limited |
Bicyclic peptide ligands specific for pd-l1
|
|
US10882987B2
(en)
|
2019-01-09 |
2021-01-05 |
Nova Chemicals (International) S.A. |
Ethylene interpolymer products having intermediate branching
|
|
GB201900528D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for integrin AVB3
|
|
GB201900529D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicycletx Ltd |
Bicyclic peptide ligands specific for CD38
|
|
GB201900525D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicycletx Ltd |
Bicyclic peptide ligands specific for caix
|
|
GB201900527D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicycletx Ltd |
Bicyclic peptide ligands specific for integrin avb3
|
|
GB201900530D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for CD38
|
|
GB201900526D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for caix
|
|
WO2020165600A1
(en)
|
2019-02-14 |
2020-08-20 |
Bicycletx Limited |
Bicyclic peptide ligand sting conjugates and uses thereof
|
|
WO2020178574A1
(en)
|
2019-03-04 |
2020-09-10 |
Bicyclerd Limited |
Synthesis of bicycle toxin conjugates, and intermediates thereof
|
|
JP2022528887A
(ja)
|
2019-04-02 |
2022-06-16 |
バイスクルテクス・リミテッド |
バイシクルトキシンコンジュゲートおよびその使用
|
|
CN113811541A
(zh)
|
2019-05-09 |
2021-12-17 |
拜斯科技术开发有限公司 |
Ox40特异性的双环肽配体
|
|
TWI869398B
(zh)
|
2019-05-10 |
2025-01-11 |
英商拜西克爾德有限公司 |
治療癌症之方法
|
|
TWI862640B
(zh)
|
2019-07-30 |
2024-11-21 |
英商拜西可泰克斯有限公司 |
異質雙環肽複合物
|
|
JP2022544246A
(ja)
|
2019-08-13 |
2022-10-17 |
バイスクルテクス・リミテッド |
修飾された多量体二環式ペプチドリガンド
|
|
GB201912320D0
(en)
|
2019-08-28 |
2019-10-09 |
Bicycletx Ltd |
PBP Binding Bicyclic Peptide Ligands
|
|
PL4464721T3
(pl)
|
2019-10-03 |
2025-08-25 |
Bicycletx Limited |
Heterotandemowe kompleksy peptydów bicyklicznych
|
|
GB201914872D0
(en)
|
2019-10-15 |
2019-11-27 |
Bicycletx Ltd |
Bicyclic peptide ligand drug conjugates
|
|
WO2021074647A1
(en)
|
2019-10-16 |
2021-04-22 |
Bicyclerd Limited |
Methods for treating cancer
|
|
IL293200A
(en)
|
2019-11-27 |
2022-07-01 |
Bicycletx Ltd |
Bicyclic peptide ligands specific for epha2 and uses thereof
|
|
IT202000001231A1
(it)
|
2020-01-22 |
2021-07-22 |
Celery S R L |
Nuovi ceppi di batteri lattici, composizione alimentare che li comprende, preparazione di tale composizione
|
|
GB202002706D0
(en)
|
2020-02-26 |
2020-04-08 |
Bicycletx Ltd |
Pbp3 binding bicyclic peptide ligands
|
|
GB202002705D0
(en)
|
2020-02-26 |
2020-04-08 |
Bicycletx Ltd |
Anti-infective bicyclic peptide conjugates
|
|
IL298382A
(en)
|
2020-05-20 |
2023-01-01 |
Bicycletx Ltd |
Nectin-4-specific bicyclic peptide ligands and their uses
|
|
IL298868A
(en)
|
2020-06-12 |
2023-02-01 |
Bicycletx Ltd |
Treatment of diseases characterized by overexpression of erythropoietin-producing hepatocellular receptor a2 (epha2)
|
|
US20220031858A1
(en)
|
2020-08-03 |
2022-02-03 |
Bicycle TX Limited |
Novel linkers
|
|
KR20230074721A
(ko)
|
2020-08-17 |
2023-05-31 |
바이사이클티엑스 리미티드 |
Nectin-4에 특이적인 이환 콘쥬게이트 및 이의 용도
|
|
EP4274837A1
(en)
|
2021-01-08 |
2023-11-15 |
BicycleTx Limited |
Anti-infective bicyclic peptide ligands
|
|
US20240197897A1
(en)
|
2021-01-08 |
2024-06-20 |
Bicycle TX Limited |
Heterotandem bicyclic peptide complexes
|
|
DK4274838T3
(da)
|
2021-01-08 |
2024-10-21 |
Bicycletx Ltd |
Bicykliske peptidligander, der er specifikke for NK-celler
|
|
US20250186539A2
(en)
|
2021-01-11 |
2025-06-12 |
Bicycletx Limited |
Methods for treating cancer
|
|
CA3229976A1
(en)
|
2021-09-03 |
2023-03-09 |
Bicycletx Limited |
Synthesis of bicycle toxin conjugates, and intermediates thereof
|
|
JP2024543505A
(ja)
|
2021-11-16 |
2024-11-21 |
バイスクルテクス・リミテッド |
癌の治療方法
|